Results 81 to 90 of about 1,483,959 (183)
Selinexor targets molecular pathways critical to myelofibrosis (MF) progenitor cell fitness and demonstrates complementary activity with ruxolitinib, supporting its potential as a novel disease‐modifying therapeutic strategy for MF. Summary Myelofibrosis (MF) is a chronic myeloproliferative neoplasm (MPN) characterized by splenomegaly, constitutional ...
Trinayan Kashyap +7 more
wiley +1 more source
ABSTRACT Ten‐Eleven Translocation 2 (TET2) is an Fe(II)‐ and α‐ketoglutarate‐dependent dioxygenase that initiates active DNA demethylation by oxidizing 5‐methylcytosine (5mC). Beyond this enzymatic role, TET2 links DNA methylation dynamics with chromatin regulation, cellular metabolism, immune‐cell identity, and treatment response in a context ...
XiaoJie Liu +5 more
wiley +1 more source
Essential thrombocythemia (ET) is an indolent myeloproliferative neoplasm (MPN) with a transformation to acute myeloid leukemia in
Toshie Ogasawara +7 more
doaj +1 more source
Polycythemia vera (PV) is a myeloproliferative neoplasm characterized by increased red cell mass and a high risk of thrombosis, considered as a major cause of mortality and morbidity in this disease.
M. Brusson +10 more
semanticscholar +1 more source
ABSTRACT Introduction Lung adenocarcinoma commonly causes malignant pleural effusion (MPE), a condition with poor prognosis and limited treatment options. Pleural effusion specimens offer a minimally invasive source for diagnosis and molecular testing.
Harpreet Virk +5 more
wiley +1 more source
Influence of JAK2V617F allele burden on phenotype in essential thrombocythemia
Background Fifty to sixty percent of patients with essential thrombocythemia harbor the JAK2V617F mutation. The impact of this mutation on clinical phenotype is still debated.
Elisabetta Antonioli +11 more
doaj +1 more source
American Journal of Hematology, Volume 101, Issue 9, Page 2463-2468, September 2026.
Rodrigo Ortega Perez +19 more
wiley +1 more source
Autoimmunity and peginterferon therapy for polycythemia vera
Abstract Peginterferon‑α is useful to treat myeloproliferative neoplasms (MPNs) but can precipitate broad autoimmunity. By promoting beta‐cell, thyroid, and systemic immune injury, it can lead to Type 1 diabetes, autoimmune thyroiditis, systemic lupus erythematosus, or Sjögren's syndrome.
Etienne Rivière +8 more
wiley +1 more source
Molecular approach to diagnose BCR/ABL negative chronic myeloproliferative neoplasms
Chronic myeloproliferative neoplasms arise from clonal proliferation of hematopoietic stem cells. According to the World Health Organization myeloproliferative neoplasms are classified as: chronic myelogenous leukemia, polycythemia vera, essential ...
Michelle Maccarini Barcelos +1 more
doaj +1 more source
Thrombophilia Screening: Little Role for the JAK2V617F Mutation [PDF]
P.M. Mannucci, F. Peyvandi
openaire +3 more sources

